Medical schools have a major impact on future doctors’ ethics and their attitudes towards cooperation with the pharmaceutical industry. From childhood, medical students who are related to a physician are exposed to the characteristics of a medical career and learn its professional ethics not only in school but also in the family setting. The present paper sought to answer the research question: ‘How does growing up with a physician influence medical students' perceptions of conflicts of interest in their relationships with (...) industry?’ An anonymous questionnaire was completed by 451 medical students from four Philadelphia medical schools and 554 medical students from Warsaw Medical University during 2013. Medical schools in these two cities were chosen because they are both university cities with similar population sizes. Students who had and who did not have a family member working as a physician were compared using chi-square analysis. Data were analysed for each country separately. For both the US and Poland, there were statistically significant differences between medical students with a physician as a family member and other students with respect to views regarding relationship with the pharmaceutical industry. In both groups, this difference occurred for three important dimensions: students’ relationship with the pharmaceutical industry; students’ views on physicians’ rights to cooperate with the pharmaceutical industry; trust in the pharmaceutical industry. In the US, students related to a doctor were characterized by more restrictive opinions on all three dimensions than other students. However, the contrary was observed in Poland: students with a physician in the family had less strict views than their colleagues. In Poland, a former communist country, physicians transmit a more liberal approach towards collaboration with the pharmaceutical industry to their student relatives than those in the US. (shrink)

It is reported that medical students both in the U.S. and Poland have experience of interacting with pharmaceutical company representatives (pharma reps) during their school years. Studies have warned that the interaction typically initiated by the pharma reps’ general gift-giving eventually leads to the quid pro quo relationship between the pharma company and the future doctors, the result of which is that the doctors will prescribe their patients drugs in favor of the pharma company. Built upon the existing finding, this (...) research engages in analysis with three foci. The first is to compare attitudinal differences of the American and Polish medical students as they interact with pharma reps. Second, it investigates the role of the different economic and cultural elements (respectively in the U.S. and Poland) in the students’ attitudinal differences. Last, it suggests that the medical schools in both countries should have strict policies and effective education curriculum to help their students better prepare to interact ethically with pharma reps. Since there has been no direct comparative cultural analysis of this kind which is known in a published literature or report, the authors believe that the paper will serve as a catalyst for further research in the area. (shrink)

This paper attempts an overview on the ethical issues of pharmaceutical industry gift-giving in the United States of America. The article shows that law is not the only way in which the relationship between physicians and pharmaceutical industry can be regulated. Most important professional associations of physicians, pharmacists, residents etc. consider industry gifts as a conflict of interest. They created different ethical guidelines for this complicated issue. The paper demonstrates various solutions of ethical matters in the relationship between physicians and (...) pharmaceutical industry by analyzing codes and guidelines of different associations. On the one hand it shows organizations which allow exchanging of gifts of no value. On the other hand it presents associations that forbid physicians accepting even a pen. The article also shows various attitudes of these associations to situations like inviting physicians to dinner, accepting drug samples, taking subsidies from the company to defray the cost of the conference etc. The problem of those relations has been neglected for long time. From society’s point of view it is important for physicians to be informed about the rules and ways that pharmaceutical companies try to influence physicians’ prescription habits. (shrink)

The involvement of the pharmaceutical industry in medical education can be seen as something completely natural. Who better than the producer of the med-icine would know how the drug was developed, how the process of it being au-thorized for sale proceeded, and what the side effects of it are? Today in the United States, more and more colleges are implementing strong pharmaceutical conflict-of-interest policies. Interaction between students and medical school staff with these companies is undesirable, because they share marketing materi-als (...) more often than honest data, and their representatives use various ways to influence these current and future physicians during their meetings. This article will describe research which shows what pharmaceutical mar-keting directed at students looks like in the USA – its character, frequency, and potential impact on future medical decisions. Also, ways of regulating interac-tion between medical schools, their staff and students and the pharmaceutical industry will be expressed. Guidelines of the Association of American Medical Colleges, the Institute of Medicine and the American Medical Student Associa-tion will be described. At the end, questions about their influence on reality and whether medical schools’ policies can be an effective barrier for pharmaceutical marketing on medical schools will be asked. (shrink)

Over the last few years, the pharmaceutical industry intensified marketing activity in Poland. One of the most important ways of promotion are visits by pharmaceutical sales representatives in physicians’ offices. Representatives during those meetings are using different sorts of tactics to manipulate physicians such as: gift-giving, free meals, travel subsidies, “fake” research, ‘white Saturdays’, sponsored teaching and conferences. An ethical ambiguity can be easily find in this work. The paper describes briefly the results of the research concerning the influence of (...) the relationship between physicians with the pharmaceutical companies on prescribing habits which were conducted in other countries. The article presents law regulations and ethical codes present in Poland, but it concentrate on describing the results of 31 in-depth interviews with pharmaceutical sales representatives conducted between the June – November 2007. The main aim of this paper is to show how important are ethical and law standards for the pharmaceutical sales representative. Do they know it? Does companies take care about proper training and information in the area for their employees? Work ethics of the pharmaceutical sales representative is very important, and should be discussed. Drugs are special kind of goods which can influence people health and sometimes even lives so we should pay attention to the ways medicaments are advertise and promote. (shrink)

Over the recent years more and more often we can hear in public debate that pharmaceutical industry is using aggressive marketing to increase the market growth. Their marketing actions are addressed mainly to physicians, because doctors are those who raise gains of pharmaceutical companies in the most considerable extent. The main aim of this paper is to answer the question what kinds of methods pharmaceutical companies are using to influence physicians’ prescribing practice. On examples will be shown how pharmaceutical sales (...) representatives are using reciprocity rule, liking, contrast, authority, scarcity, social proof and consistence to manipulate on doctors. The paper will try to answer the questions: Are physicians aware of influence of pharmaceutical companies? What should be done to increase their awareness? The article is based on the CAWI research. It is analysis of 372 questionnaires filled by physicians. Research was conducted with the support of Medycyna Praktyczna site – one of the most famous websites among the doctors in Poland. (shrink)

An anonymous survey distributed to doctors in Poland revealed the troublesome relationship between physicians and pharmaceutical sale representatives in terms of the frequency of visits, the trust of physicians in information supplied by sales reps, gifts accepted, and the general influence of marketing strategies on physician decisions. Challenges remain, despite laws enacted to address the problem.

The burden of social responsibility is on the pharmaceutical industry. It is producing drugs and medical equipment which have to fulfill high quality standards, because they are very important from society point of view. The main business activity of pharmaceutical companies can be assessed as doing something good. However, a lot of drug producers are also involved in other ways of working for public wellness. There are using a great range of the instruments and programs to manage the corporate social (...) responsibility. The article describes the results of 31 in-depth interviews with the pharmaceutical sales representatives conducted between the June – November 2007. It shows what problems can be created during organizing: charity action, white Sundays, conferences for physicians and other pro bono events. It explains how such actions can meet with public opinion accusations. The main aim of this paper is to answer the questions: What are the advantages of realizing CSR for pharmaceutical companies? Is it true that this conception is used as a marketing tool by drug producers? What the pharmaceutical sales representatives think about charity actions that are conducted in their companies? (shrink)

Within last twenty years in the European Union much regulation concerning advertisements of drugs changed. The aggressive marketing operations of producers of medicines caused that new solutions, not only legal but also ethical, had appeared. The European Union is imposing reliable solutions upon its members in the form of directives to which they must adapt their law. They can however decide to choose stricter law than the one which is recommended to them. The European Federation of Pharmaceutical Industry and Associations (...) – voluntary organization consisting associations of pharmaceutical companies from lots of countries is acting on similar principles. Each of the members belonging to it can implement its own, more restrictive regulation in the national ethical code than a Federation is ordering. Main purpose of this article is reading what legal and ethical solutions of pharmaceutical marketing were accepted in selected countries of the European Union. Whether they are stricter than the ones imposed upon them by European Union? How in this background Polish regulations are looking like? In the article also examples of the law-breaking and ethical principles by producers of medicines in the European Union will be presented. It will show sanctions taken out towards them for this reason. A question will be put: are various penalties able effectively to scare the pharmaceutical industry off the unethical or even unlawful advertising? (shrink)

Relationships between physicians and pharmaceutical sales representatives (PSRs) often create conflicts of interest, not least because of the various benefits received by physicians. Many countries attempt to control pharmaceutical industry marketing strategies through legal regulation, and this is true in Poland where efforts are underway to eliminate any practices that might be considered corrupt in medicine. The present research considered Polish medical students’ opinions about domestic laws restricting doctors’ acceptance of expensive gifts from the industry, the idea of compulsory transparency, (...) and the possibility of introducing a Polish Sunshine Law. A qualitative, focus group-based, interview method was used. Data were gathered from nine focus groups involving 92 medical students from three universities located in major Polish cities. The article presents a classification of opposing student views with regard to the consequences of introducing different legal solutions; this should be useful for policy makers deliberating on how to optimally regulate pharmaceutical marketing. The study’s results are discussed in the context of the public bioethical debate in Poland. (shrink)